RxDoctor Payments Data

Steven James, PA

Physician Assistant · Lafayette, TNNPI 1477710887

Payments from drug & device makers

$1,560in general payments, 2019–2025

Across 74 payments — averaging $21.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$401
  • AstraZeneca$256
  • Novo Nordisk$193
  • Otsuka America Pharmaceutical, Inc.$147
  • Lilly USA, LLC$137
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$130
  • plus $297 from 7 others

What the payments were for

  • Food & beverage$1,560100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,560 in reported general payments places this provider in the 75th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$28,041
Medicare patients
118
Services billed
709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide57$72,045
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$49,983
JardianceEmpagliflozin52$47,013
TrulicityDulaglutide39$46,382
XareltoRivaroxaban22$31,101
MounjaroTirzepatide30$29,886
EliquisApixaban25$22,162
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog21$19,092
JanumetSitagliptin Phos/Metformin Hcl13$17,520
LinzessLinaclotide19$13,584
MyrbetriqMirabegron14$12,646
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$12,289
FarxigaDapagliflozin Propanediol13$11,642
Spiriva RespimatTiotropium Bromide14$11,517
Breo ElliptaFluticasone/Vilanterol11$6,336

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$137$76,26869 claims
Novo NordiskOzempic$193$72,04557 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$65$68,60771 claims
Boehringer IngelheimJardiance, Spiriva Respimat$38$58,53066 claims
PfizerEliquis$33$22,16225 claims
AstraZenecaFarxiga, Brilinta$256$16,25448 claims
AbbVieLinzess$401$13,58419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Lafayette

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →